5 results
P0042 - Open-label treatment with olanzapine in patients with borderline personality disorder
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S93
-
- Article
-
- You have access
- Export citation
Olanzapine-fluoxetine combination in treatment-resistant depression
-
- Journal:
- European Psychiatry / Volume 17 / Issue S1 / May 2002
- Published online by Cambridge University Press:
- 16 April 2020, p. 98s
-
- Article
-
- You have access
- Export citation
Olanzapine for the treatment of borderline personality disorder: A flexible-dose 12-week randomized double-blind placebo-controlled study
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, p. S172
-
- Article
-
- You have access
- Export citation
A dose comparison of olanzapine for the treatment of borderline personality disorder: A 12-week randomized double-blind placebo-controlled study
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, pp. S172-S173
-
- Article
-
- You have access
- Export citation
Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study
-
- Journal:
- The British Journal of Psychiatry / Volume 193 / Issue 6 / December 2008
- Published online by Cambridge University Press:
- 02 January 2018, pp. 485-492
- Print publication:
- December 2008
-
- Article
-
- You have access
- HTML
- Export citation